Feedback / Questions
CTX320 - CRISPR Therap
https://www.globenewswire.com/news-release/2025/06/26/3105698/0/en/CRISPR-Therapeutics-Reports-Positive-Additional-Phase-1-Data-for-CTX310-Targeting-ANGPTL3-and-Provides-Update-on-In-Vivo-Cardiovascular-Pipeline.html
Jun 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next